The research team, led by Wang, Dong, Song and colleagues, tackled a long-standing technical problem in cardiovascular biology. Single-cell RNA sequencing can reveal which genes are active in individual cells, but the process typically requires dissociating tissue into a suspension, stripping away the crucial information about where each cell actually sat within the organ. Spatial transcriptomics, by contrast, preserves that positional information but has traditionally offered lower resolution or less complete coverage of the transcriptome. The researchers reasoned that neither approach alone would be sufficient to understand a process as architecturally dependent as heart maturation, in which a cardiomyocyte in the outer wall of the ventricle may follow a different developmental program than its neighbor deeper in the muscle.

Their solution was to integrate the two technologies in a single, coordinated framework. First, they performed single-nucleus RNA sequencing, a technique that captures RNA from individual nuclei rather than whole cells. This choice is particularly important for heart tissue, where mature cardiomyocytes are large, densely packed, and notoriously difficult to dissociate intact. Working with nuclei allowed the team to profile a far more representative sample of the postnatal myocardium, including the very cell types that are hardest to recover by conventional methods. In parallel, they generated spatial transcriptomic maps of heart sections at multiple postnatal time points, capturing the gene-expression landscapes of intact tissue.

By computationally aligning these two data streams, the researchers built what they describe as a spatially guided, single-cell functional genomic atlas of the postnatal heart. In practical terms, the atlas assigns each of thousands of profiled nuclei not only a molecular identity but also a likely physical address within the developing organ, and it tracks how those identities and addresses change across the critical postnatal window. The result is a spatiotemporal map of heart maturation: a record of which cells live where, which genes they switch on and off, and how the developmental program is orchestrated across the whole organ rather than in isolated dissociated fragments.

One of the study’s central achievements is the catalog of regulatory factors it identifies as controllers of cardiomyocyte maturation. Sifting through the enormous amount of gene-expression data, the team pinpointed twenty-one distinct regulators whose activity patterns coincide with, and in functional tests help drive, the maturation of heart muscle cells. Maturation, in this context, means the suite of changes through which neonatal cardiomyocytes abandon their proliferative, fetal-like state and acquire the adult phenotype: enlarged cell size, organized sarcomeres, abundant mitochondria, and the characteristic electrical and metabolic properties of working heart muscle. Understanding which molecular switches govern this transition has been a goal of the field for decades, partly because the loss of proliferative capacity that accompanies maturation explains why the adult heart cannot effectively regenerate after injury.

Why does that matter for human medicine? Heart disease remains the leading cause of death worldwide, and much of its burden stems from the heart’s inability to replace damaged muscle after a heart attack. The neonatal window, during which cardiomyocytes retain a limited capacity to divide, represents biology’s own demonstration that heart muscle regeneration is possible—if the right programs are in place. By identifying the regulators that actively push cells out of that permissive state, the new atlas gives researchers a molecular roadmap of the barriers that stand between an injured, failing heart and self-repair. Several of the twenty-one regulators identified in the study may prove to be druggable nodes whose manipulation could, in principle, reawaken regenerative potential in adult tissue.

Beyond the individual cell type, the study reveals that maturation is a coordinated, spatially organized phenomenon. The researchers uncovered a regulatory network in which maturation signals are patterned across the heart in a spatially coordinated fashion, suggesting that the organ functions as an integrated developmental system rather than a collection of independently maturing cells. Cells in different regions of the postnatal heart encounter distinct microenvironments—different neighbors, different mechanical stresses, different exposure to blood-borne signals—and the atlas shows how these positional cues are written into the gene-expression programs of the cells that experience them. This spatial coordination likely ensures that the electrical conduction pathways, the thickness of the ventricular walls, and the architecture of the valves and vasculature mature in synchrony, so that the organ comes online as a coherent pump.

The methodological advance at the heart of the study is itself noteworthy. Integrating single-nucleus and spatial data requires sophisticated computational tools: the two technologies measure overlapping but not identical sets of genes, at different resolutions, from different physical samples. The team’s integration strategy allowed them to transfer the high-resolution molecular detail of single-nucleus sequencing onto the spatial scaffolds provided by transcriptomic mapping, effectively getting the best of both worlds. As such approaches mature, they are expected to become standard practice across developmental biology and pathology, because so many biological questions—from organ formation to tumor progression—turn on precisely where in a tissue specific molecular events occur.

The postnatal heart atlas is also likely to become a community resource. High-resolution, time-resolved maps of this kind serve as reference datasets against which researchers can compare disease models, drug treatments, and engineered tissues. A laboratory testing a gene therapy intended to stimulate cardiomyocyte proliferation, for example, can now ask in molecular detail whether treated cells resemble their neonatal precursors or instead follow an aberrant path. The atlas documents normal maturation in enough depth that deviations from it become interpretable, accelerating the translation of basic developmental insights into regenerative strategies.

For a field that has long studied the heart either as a pumping organ or as a collection of dissociated cells, the message of the new work is that maturation lives in the intersection: in the dialogue between a cell’s identity and its location, between time and space. By capturing that dialogue in a single integrated framework, Wang, Dong, Song and colleagues have transformed a murky developmental transition into a navigable molecular landscape—and in doing so, they have handed regenerative medicine a much more detailed map of the territory it hopes to conquer.

Subject of Research: Spatially resolved single-cell functional genomics of postnatal mouse heart maturation

Article Title: Spatially guided in vivo single-cell functional genomics of postnatal heart

Article References: Wang, H., Dong, Y., Song, Y., Colon, M., Grosso, C., Yapundich, N., Ricketts, S., Liu, X., Farber, G., Liu, S. L., Qian, Y., Qian, L., & Liu, J. (2026). Spatially guided in vivo single-cell functional genomics of postnatal heart. Nature Cardiovascular Research, 5(9), 848-868. https://doi.org/10.1038/s44161-026-00861-z

Image Credits: AI Generated

DOI: 10.1038/s44161-026-00861-z

Keywords: single-nucleus RNA sequencing, spatial transcriptomics, cardiomyocyte maturation, postnatal heart development, heart regeneration, gene regulation, mouse heart atlas, cardiovascular research, single-cell genomics, developmental biology, Spatially, guided

The significance of the study lies in the kind of animal the researchers chose. Until now, cardiac regeneration has been characterized almost exclusively in fish and amphibians, such as zebrafish and salamanders, whose hearts are structurally simple and function at low blood pressures. Mammals, including humans, largely lose this ability shortly after birth; when our hearts are injured by a heart attack, the dead muscle is replaced by scar tissue rather than new functional muscle, setting the stage for heart failure. The leopard gecko, Eublepharis macularius, changes the calculus. Its heart is more complex than that of fish and amphibians, and it operates at higher pressures, making it anatomically and functionally closer to the mammalian heart. If a reptile with a comparatively sophisticated cardiovascular system can rebuild its own cardiac muscle, the molecular rules it follows may be more transferable to human medicine than those gleaned from fish swimming in cool, low-pressure aquatic environments.

To trigger regeneration, the team injured the gecko hearts using a cryoprobe, a chilled instrument that freezes and kills a small patch of cardiac tissue in a controlled and reproducible manner. This cryoinjury model closely mimics the kind of cell death seen in a human myocardial infarction. The researchers then collected tissue samples from the wound sites at four carefully chosen time points: three, fourteen, thirty, and one hundred days after injury. They also sampled the hearts of sham-operated geckos, animals that underwent the surgical procedure without actual cryoinjury, to serve as controls. By comparing the wounded hearts against these controls at each stage, the researchers could distinguish genuine injury responses from the nonspecific effects of surgery itself.

At the heart of the study’s methodology is quantitative proteomics, the large-scale measurement of proteins within a biological sample. While genomics tells researchers which genes are present or transcribed, proteomics reveals which proteins are actually being produced and at what abundance, offering a far more direct readout of cellular behavior. The team used high-resolution mass spectrometry to identify and quantify the proteins present in each sample, applying advanced bioinformatic tools to detect proteins whose levels changed significantly over the recovery period. They compiled and validated their results using specialized databases, including one built specifically for the leopard gecko proteome, and then performed Gene Ontology and pathway analyses to translate long lists of protein names into a coherent biological narrative about what the injured heart was doing at each stage of repair.

The results were striking. Across the time course, the researchers found that 579 proteins were differentially expressed at two or more time points, a substantial molecular signature of an active and dynamic repair process. Among the most important discoveries was a rise in the abundance of agrin at fourteen days post injury. Agrin is a protein best known for its role at the neuromuscular junction, but recent work in other contexts has shown that it can facilitate cardiomyocyte dedifferentiation, the process by which mature heart muscle cells essentially revert to a more primitive, proliferative state, allowing them to divide and produce new muscle cells. The gecko heart’s decision to ramp up agrin production precisely at the midpoint of its repair program suggests that dedifferentiation of existing heart muscle cells is a central mechanism of the regenerative response. This is the first report of injury-induced agrin upregulation in cardiac tissue, a finding that immediately suggests new avenues for therapeutic exploration in mammalian systems.

The Gene Ontology analysis painted a vivid picture of the metabolic and structural remodeling that accompanies regeneration. By fourteen days after injury, the wound site showed a coordinated decrease in oxidative phosphorylation and glycolytic capacity, indicating that the injured tissue had temporarily dialed down its energy production machinery. At the same time, the proteomic signatures of sarcomere organization, the intricate array of protein filaments that gives heart muscle cells their contractile power, and of mitochondrial content were markedly reduced. In essence, the cells at the injury site appeared to be dismantling their mature, specialized equipment, a hallmark of dedifferentiation. Heat shock proteins, molecular chaperones that stabilize and refold damaged proteins, were also modulated during this window, consistent with a tissue under acute stress while simultaneously reprogramming itself for growth.

What happened next is what makes the gecko heart so remarkable. By thirty days after injury, the regenerative program was visibly advancing, and by one hundred days the researchers could detect no Gene Ontology terms that differed between the regenerated hearts and those of sham-operated controls. The sarcomere organization had been rebuilt, mitochondrial populations had been restored, and the metabolic machinery of oxidative phosphorylation and glycolysis had returned to its baseline state. In other words, the gecko heart did not simply patch over the wound with scar tissue; it reconstructed the cellular architecture of the injury site so completely that, at the level of the proteome, the repaired tissue was indistinguishable from tissue that had never been damaged at all. This return to a pre-injury molecular state is the defining feature of true regeneration, and it is precisely what the mammalian heart fails to achieve.

The study’s conclusions emphasize that gecko heart regeneration involves the coordinated reorganization of cellular pathways governing mitosis, energy production, and contractile function. Rather than a single magic-bullet factor, regeneration appears to be a carefully timed sequence in which mature cardiomyocytes dedifferentiate, proliferate, and then redifferentiate, with the cell’s metabolic identity shifting in parallel from an energy-consuming, growth-oriented state back to the highly oxidative phenotype of a working heart muscle cell. The temporal resolution of the study, sampling at multiple stages across one hundred days, allowed the team to observe this sequence as it unfolded, capturing both the dismantling phase in the first two weeks and the reconstruction phase in the weeks that followed.

For the field of regenerative medicine, the implications are considerable. If the pathways that the gecko heart uses, including agrin-driven dedifferentiation, transient metabolic downregulation, and subsequent mitochondrial biogenesis, can be understood in sufficient molecular detail, researchers may be able to coax the mammalian heart into reactivating vestiges of these same ancestral programs. The finding that agrin expression rises after cardiac injury in a regenerating species is particularly compelling because agrin has already attracted attention as a possible therapeutic candidate, and the gecko data provide fresh evidence that this pathway is deployed during natural regeneration in a vertebrate with a complex, high-pressure heart. The researchers also note that proteins such as fibronectin, a component of the extracellular matrix involved in wound healing, showed dynamic changes across the time course, underscoring the importance of the structural scaffold on which new tissue is built.

The work also elevates the leopard gecko itself as an experimental model. Reptiles have been largely overlooked in regeneration research compared with fish and amphibians, yet the gecko has already demonstrated the ability to regenerate other tissues, and this study confirms that its cardiac regenerative capacity is robust and mechanistically accessible. The authors, led by Reece R. B. Long and senior investigators Todd E. Gillis, Matt K. Vickaryous, and Jennifer Geddes-McAlister at the University of Guelph, made their extensive proteomic datasets openly available as supplementary files, allowing other laboratories to mine the data for additional regenerative signatures. The research was funded by the Natural Sciences and Engineering Research Council of Canada, and all experiments were conducted under approved animal care protocols in accordance with national guidelines.

There remain, of course, many questions to answer. The proteomic approach reveals which proteins change in abundance but not always how they are regulated or what happens at the level of individual cells, and future studies combining proteomics with single-cell transcriptomics, imaging, and functional assays will be needed to fully dissect the gecko’s repair program. Nevertheless, the core message of the study is clear and hopeful: a vertebrate with a structurally complex, high-pressure heart can rebuild that heart completely after injury, and the molecular blueprint it uses is now coming into focus. In the gecko’s quiet, methodical restoration of its own cardiac muscle, researchers may be glimpsing a lost capacity of our own biology, one that modern medicine might eventually learn to reactivate in the millions of patients whose hearts cannot heal themselves.